🔍 This innovation enhances real-time process monitoring, increasing precision and efficiency in biomanufacturing.
💡 According to Bryan Hassell, CTO, it addresses challenges in optical fluid analysis, empowering manufacturers with data-driven tools for better decisions.
📈 The technology features active temperature regulation and precise optical control for high-quality data.
Introduction:
Nirrin Technologies has been granted U.S. Patent 12,222,279 B2 for its innovative flow-cell technology designed for in-bioprocess analytics, marking a significant advancement in the field of real-time process monitoring in biopharmaceutical manufacturing.
- Nirrin Technologies has received a patent for its flow-cell technology, enhancing capabilities in bioprocess analytics.
- This technology provides improved real-time monitoring of bioprocessing workflows, aimed at increasing precision and efficiency.
- Key features include active temperature regulation and precise optical path control, contributing to data consistency and quality.
- Dr. Bryan Hassell, CTO, emphasized the technology’s role in advancing Biopharma 4.0 with data-driven insights that support better decision-making.
- The integration of these features positions Nirrin Technologies as a leader in optimizing bioprocessing methodologies.
Conclusion:
The granting of this patent represents a pivotal development in bioprocess analytics, underscoring Nirrin Technologies’ commitment to enhancing biopharmaceutical manufacturing. As the industry moves towards more data-driven practices, this technology may play a crucial role in shaping the future of bioprocess optimization.
